| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE | 35 |
| 1 | SECUKINUMAB | 28 |
| 2 | FINGOLIMOD HCL | 27 |
| 3 | ETANERCEPT | 21 |
| 4 | ESTRADIOL | 20 |
| 5 | SILDENAFIL CITRATE | 20 |
| 6 | CONJUGATED ESTROGENS | 14 |
| 7 | ESTROGENS, CONJUGATED | 14 |
| 8 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 14 |
| 9 | MYCOPHENOLATE MOFETIL | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIPOTRIENE CREAM, 0.005% | 1 | 0.0097 |
| 1 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 3 | 0.0078 |
| 2 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 3 | VORASIDENIB | 2 | 0.0033 |
| 4 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | BACILLUS CALMETTE-GUERIN | 2 | 0.0011 |
| 6 | MONOMETHYL FUMARATE | 1 | 0.0011 |
| 7 | ALPROSTADIL | 3 | 0.0008 |
| 8 | BEXAROTENE | 1 | 0.0008 |
| 9 | CHLORZOXAZONE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 47 |
| 1 | Interleukin-17A Antagonist [EPC] | 28 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 3 | Progestin [EPC] | 12 |
| 4 | Kinase Inhibitor [EPC] | 11 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 6 | Nucleoside Analog Antiviral [EPC] | 11 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 10 |
| 8 | Partial Opioid Agonist [EPC] | 9 |
| 9 | Androgen [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 3 | Interleukin-17A Antagonist [EPC] | 28 | 0.0008 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Androgen [EPC] | 8 | 0.0003 |
| 7 | Estrogen [EPC] | 47 | 0.0003 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 10 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |